PR86418

HYDERABAD, India and CAMBRIDGE, Mass., Nov. 5, 2020 /PRNewswire=KYODO JBN/ --

    Excelra [https://www.excelra.com/], a leading global data science & data

analytics company, and Cellarity, a flagship pioneering company working on the

development of a new generation of medicines to treat diseases at the level of

cell behaviours, have today announced an agreement whereby Excelra will provide

Cellarity access to its Global Online Structure Activity Relationship database

(GOSTAR).

    GOSTAR [https://www.excelra.com/discovery/#gostar] is the world's largest

small molecule medicinal chemistry intelligence platform that encompasses over

8 million compounds, linking chemical structure to biological, pharmacological

and therapeutic activities. With a vast knowledge base of 28 million SAR data

points, GOSTAR equips researchers in the early as well as optimization stages

of drug discovery.

    Cellarity's drug discovery platform uses high-resolution biological data

and unique machine learning capabilities to pioneer an entirely new approach to

drug discovery. Cellarity is designing medicines that target and change cell

behaviors to unlock treatments in a large number of disease areas. "We are

looking forward to using high quality annotated GOSTAR data on millions of

small molecules, while leveraging Cellarity's proprietary AI/ML modules to

generate predictable drug-like molecules that ultimately guide the design of

novel Cell Behavior-Targeted therapies. Our preliminary assessment gives us the

confidence in the utility of GOSTAR database," said Ramakanth Sarabu, Head of

Chemistry, Cellarity.

    "GOSTAR is a widely used structure activity relationship database in AI/ML

driven drug discovery programs. We strongly believe that this collaboration

equips AI/ML and medicinal chemistry researchers at Cellarity to utilize

curated interactions of millions of small molecules with potential drug targets

to generate novel compounds with desired pharmacological profiles," said

Raveendra Dayam, Director, Chemistry Services, Excelra.

About Cellarity:

    Cellarity is a first-of-its-kind therapeutics company that is discovering

and developing medicines by studying and altering cell behaviors. Cellarity has

developed a powerful, generalizable platform harnessing single-cell

technologies, machine learning and proprietary data models of disease to unveil

the network state of a given cell. The platform digitizes and quantifies

cellular behaviors, unravels the network dynamics that govern those behaviors,

and generates medicines that can direct them. https://cellarity.com/

About Excelra:

    Excelra's data science and data analytics solutions empower innovation in

life sciences. The Excelra Edge comes from a seamless amalgamation of

proprietary data assets, domain expertise and data science to accelerate drug

discovery & development. Visit www.excelra.com

Contact:

Dorothy Paul- Director Marketing

dorothy.paul@excelra.com

Logo: https://mma.prnewswire.com/media/692189/Excelra_Logo.jpg

Source: Excelra Knowledge Solutions Pvt Ltd